Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic factors and staging in multiple myeloma.

Hematology/oncology clinics of North America - 1 Dec 2007

Fonseca Rafael, San Miguel Jesus

Abstract excerpt

The field of multiple myeloma prognostication is replete with studies that have shown the value of independent predictors in determining clinical outcome. It is clear that host factors and factors intrinsic to the cells are the ultimate determinants of prognosis. In the immediate period after dia...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Chromosomes, Human, Pair 13
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy

Share to Hematopoietic Stem Cell Transplantation

Share to Multiple Myeloma

Share to Neoplasm Staging

Share to Prognosis

Source

Identifiers

PMID: 17996591
DOI: 10.1016/j.hoc.2007.08.010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17996591-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic factors and staging in multiple myeloma.PMID 17996591Read ↗

Advances in understanding prognosis in myeloma.Semantic proximity Read ↗

The use of biological variables to predict outcome in multiple myeloma.Semantic proximity Read ↗

Haematopoietic Score for the Prognostic Evaluation of Multiple Myeloma Patients Undergoing First-line Treatment With a Bortezomib-based RegimenSemantic proximity Read ↗

Role of genetics in prognostication in myelomaSemantic proximity Read ↗

[Molecular genetic methods for the prognostic criteria in multiple myeloma].Semantic proximity Read ↗

Hypodiploidy is a major prognostic factor in multiple myelomaSemantic proximity Read ↗

[Recent biological and therapeutic advances in multiple myeloma].Semantic proximity Read ↗

Telomere length is a critical determinant for survival in multiple myelomaSemantic proximity Read ↗

Hematopoietic Score for the Prognostic Evaluation of Multiple Myeloma Patients Undergoing First-Line Treatment With A Bortezomib-Based RegimenSemantic proximity Read ↗

The flow-cytometric DNA content of the plasma cells of patients with multiple myeloma is a prognostic factor: a single institution experienceSemantic proximity Read ↗

Cellular resistance mechanisms with impact on the therapy of multiple myeloma.Semantic proximity Read ↗

Prognostic role of TNF alpha, LT alpha, MDR1 and codon 72 Tp53 gene polymorphisms on multiple myeloma Egyptian patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.